These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24758762)

  • 1. C1GALT1 overexpression promotes the invasive behavior of colon cancer cells through modifying O-glycosylation of FGFR2.
    Hung JS; Huang J; Lin YC; Huang MJ; Lee PH; Lai HS; Liang JT; Huang MC
    Oncotarget; 2014 Apr; 5(8):2096-106. PubMed ID: 24758762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C1GALT1 enhances proliferation of hepatocellular carcinoma cells via modulating MET glycosylation and dimerization.
    Wu YM; Liu CH; Huang MJ; Lai HS; Lee PH; Hu RH; Huang MC
    Cancer Res; 2013 Sep; 73(17):5580-90. PubMed ID: 23832667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer.
    Lee PC; Chen ST; Kuo TC; Lin TC; Lin MC; Huang J; Hung JS; Hsu CL; Juan HF; Lee PH; Huang MC
    Oncogene; 2020 Mar; 39(13):2724-2740. PubMed ID: 32005975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C1GALT1 promotes invasive phenotypes of hepatocellular carcinoma cells by modulating integrin β1 glycosylation and activity.
    Liu CH; Hu RH; Huang MJ; Lai IR; Chen CH; Lai HS; Wu YM; Huang MC
    PLoS One; 2014; 9(8):e94995. PubMed ID: 25089569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of C1GALT1 promotes breast cancer cell growth through MUC1-C signaling pathway.
    Chou CH; Huang MJ; Chen CH; Shyu MK; Huang J; Hung JS; Huang CS; Huang MC
    Oncotarget; 2015 Mar; 6(8):6123-35. PubMed ID: 25762620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C1GALT1-mediated O-glycan T antigen increase enhances the migration and invasion ability of gastric cancer cells.
    Bao X; Yu H; Chen Z; Chen W; Xiao Y; Wu X; Li Z
    Biochem Biophys Res Commun; 2024 Nov; 734():150641. PubMed ID: 39243676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C1GALT1 high expression is associated with poor survival of patients with pancreatic ductal adenocarcinoma and promotes cell invasiveness through integrin α
    Kuo TC; Wu MH; Yang SH; Chen ST; Hsu TW; Jhuang JY; Liao YY; Tien YW; Huang MC
    Oncogene; 2021 Feb; 40(7):1242-1254. PubMed ID: 33420364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C1GALT1 Seems to Promote In Vitro Disease Progression in Ovarian Cancer.
    Chou CH; Huang MJ; Liao YY; Chen CH; Huang MC
    Int J Gynecol Cancer; 2017 Jun; 27(5):863-871. PubMed ID: 28498248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C1GALT1 predicts poor prognosis and is a potential therapeutic target in head and neck cancer.
    Lin MC; Chien PH; Wu HY; Chen ST; Juan HF; Lou PJ; Huang MC
    Oncogene; 2018 Oct; 37(43):5780-5793. PubMed ID: 29930379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered O-glycosylation is associated with inherent radioresistance and malignancy of human laryngeal carcinoma.
    Dong X; Luo Z; Wang Y; Meng L; Duan Q; Qiu L; Peng F; Shen L
    Exp Cell Res; 2018 Jan; 362(2):302-310. PubMed ID: 29179977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of C1galt1 Gene Promotes Development and Metastasis of Pancreatic Adenocarcinomas in Mice.
    Chugh S; Barkeer S; Rachagani S; Nimmakayala RK; Perumal N; Pothuraju R; Atri P; Mahapatra S; Thapa I; Talmon GA; Smith LM; Yu X; Neelamegham S; Fu J; Xia L; Ponnusamy MP; Batra SK
    Gastroenterology; 2018 Nov; 155(5):1608-1624. PubMed ID: 30086262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective Intestinal Mucin-Type O-Glycosylation Causes Spontaneous Colitis-Associated Cancer in Mice.
    Bergstrom K; Liu X; Zhao Y; Gao N; Wu Q; Song K; Cui Y; Li Y; McDaniel JM; McGee S; Chen W; Huycke MM; Houchen CW; Zenewicz LA; West CM; Chen H; Braun J; Fu J; Xia L
    Gastroenterology; 2016 Jul; 151(1):152-164.e11. PubMed ID: 27059389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twist1 correlates with poor differentiation and progression in gastric adenocarcinoma via elevation of FGFR2 expression.
    Zhu DY; Guo QS; Li YL; Cui B; Guo J; Liu JX; Li P
    World J Gastroenterol; 2014 Dec; 20(48):18306-15. PubMed ID: 25561797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C1GALT1 expression predicts a favorable prognosis and suppresses malignant phenotypes via TrkA signaling in neuroblastoma.
    Lin NY; Chen ST; Chang HL; Lu MY; Yang YL; Chou SW; Lin DT; Lin KH; Jou ST; Hsu WM; Huang MC; Chang HH
    Oncogenesis; 2022 Feb; 11(1):8. PubMed ID: 35169131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. O-GlcNAcylation determines the function of the key O-GalNAc glycosyltransferase C1GalT1 in bladder cancer.
    Jiang Y; Wu J; Guan F; Liang L; Wang Y
    Acta Biochim Biophys Sin (Shanghai); 2024 Aug; 56(8):1108-1117. PubMed ID: 39126245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Truncation of GalNAc-type O-glycans Suppresses CD44-mediated Osteoclastogenesis and Bone Metastasis in Breast Cancer.
    Lin NY; Lee JJ; Chen ST; Lin JA; Lin CH; Lin HY; Su YH; Chen CC; Lin MC; Kuo CY; Huang MC
    Mol Cancer Res; 2023 Jul; 21(7):664-674. PubMed ID: 37040171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of C1GalT1 inhibits radioresistance of human esophageal cancer cells through modifying β1-integrin glycosylation.
    Zhang C; Deng X; Qiu L; Peng F; Geng S; Shen L; Luo Z
    J Cancer; 2018; 9(15):2666-2677. PubMed ID: 30087707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance of βGal-βGalNAc-containing glycans and the enzymes involved in their synthesis for invasion and survival in breast cancer patients.
    Milde-Langosch K; Schütze D; Oliveira-Ferrer L; Wikman H; Müller V; Lebok P; Pantel K; Schröder C; Witzel I; Schumacher U
    Breast Cancer Res Treat; 2015 Jun; 151(3):515-28. PubMed ID: 25975956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. beta 1,3-Galactosyltransferase beta 3Gal-T5 acts on the GlcNAcbeta 1-->3Galbeta 1-->4GlcNAcbeta 1-->R sugar chains of carcinoembryonic antigen and other N-linked glycoproteins and is down-regulated in colon adenocarcinomas.
    Salvini R; Bardoni A; Valli M; Trinchera M
    J Biol Chem; 2001 Feb; 276(5):3564-73. PubMed ID: 11058588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular chaperone Cosmc enhances malignant behaviors of colon cancer cells via activation of Akt and ERK.
    Huang J; Che MI; Lin NY; Hung JS; Huang YT; Lin WC; Huang HC; Lee PH; Liang JT; Huang MC
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E62-71. PubMed ID: 23390052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.